Articles from Grant Avenue Capital, LLC
Grant Avenue Capital, LLC (“Grant Avenue”), a healthcare-focused, middle-market private equity firm, today announced the acquisition of 21st Century Healthcare, Inc. (“21st Century” or the “Company”), a leading provider of vitamins, minerals, and supplements (“VMS”) for both humans and pets. Terms of the transaction were not disclosed.
By Grant Avenue Capital, LLC · Via Business Wire · January 21, 2026
Grant Avenue Capital, LLC (“Grant Avenue”), a healthcare-focused, middle-market private equity firm, today announced the acquisition of PatientCare EMS Solutions (“PatientCare” or the “Company”), a leading provider of ground-based healthcare transportation services. Terms of the transaction were not disclosed.
By Grant Avenue Capital, LLC · Via Business Wire · January 7, 2026

Grant Avenue Capital, LLC (“Grant Avenue”), a lower middle market healthcare-focused private equity firm, and the founding partners of CREO, Inc. (“CREO” or the “Company”), an award-winning provider of strategy, M&A, digital transformation, cybersecurity, IT quality and regulatory compliance consulting services to life sciences and healthcare organizations, today announced a recapitalization of CREO. Terms of the transaction were not disclosed.
By Grant Avenue Capital, LLC · Via Business Wire · September 6, 2023

Fortis Home Health & Hospice (“Fortis” or the “Company”), a leading home-based care company and portfolio company of lower middle market healthcare-focused private equity firm, Grant Avenue Capital, LLC (“Grant Avenue”), today announced that Rob Radics has joined the Company as Chief Executive Officer.
By Grant Avenue Capital, LLC · Via Business Wire · June 29, 2023

Grant Avenue Capital, LLC (“Grant Avenue” or the “Firm”), a lower middle market healthcare-focused private equity firm, today announced that Brian Berkin has joined the Firm as a Managing Director, effective immediately. In this role, Mr. Berkin will be responsible for sourcing and executing investments across Grant Avenue’s subsectors of focus, including Services, Devices, Pharma & Pharma Services, and HCIT.
By Grant Avenue Capital, LLC · Via Business Wire · October 27, 2022
